Nrx Pharmaceuticals Stock Analysis
| NRXPW Stock | USD 0.05 0 2.00% |
NRx Pharmaceuticals is overvalued with Real Value of 0.0409 and Hype Value of 0.0538. The main objective of NRx Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what NRx Pharmaceuticals is worth, separate from its market price. There are two main types of NRx Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The NRx Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. NRx Pharmaceuticals is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. NRx Stock trading window is adjusted to America/New York timezone.
NRx |
NRx Stock Analysis Notes
The company recorded a loss per share of 6.25. NRx Pharmaceuticals had not issued any dividends in recent years. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded in 2015 and is based in Wilmington, Delaware. Nrx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about NRx Pharmaceuticals contact Stephen Esq at (484) 254-6134 or learn more at https://www.nrxpharma.com.NRx Pharmaceuticals Investment Alerts
| NRx Pharmaceuticals is way too risky over 90 days horizon | |
| NRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| NRx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| NRx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRx Pharmaceuticals has accumulated about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NRx Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NRX Pharmaceuticals Strengthens Leadership with New CFO Appointment - TipRanks |
NRx Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 714.61 M.NRx Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.12) | (3.92) | |
| Return On Capital Employed | 2.35 | 2.47 | |
| Return On Assets | (4.12) | (3.92) | |
| Return On Equity | 2.57 | 2.70 |
Management Efficiency
NRx Pharmaceuticals has return on total asset (ROA) of (1.1597) % which means that it has lost $1.1597 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.8261) %, meaning that it generated substantial loss on money invested by shareholders. NRx Pharmaceuticals' management efficiency ratios could be used to measure how well NRx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NRx Pharmaceuticals' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 2.70 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (3.92). At this time, NRx Pharmaceuticals' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 409.4 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (1.55) | (1.47) | |
| Tangible Book Value Per Share | (1.55) | (1.47) | |
| Enterprise Value Over EBITDA | (1.31) | (1.25) | |
| Price Book Value Ratio | (2.97) | (2.82) | |
| Enterprise Value Multiple | (1.31) | (1.25) | |
| Price Fair Value | (2.97) | (2.82) | |
| Enterprise Value | 39.4 M | 37.4 M |
Effective leadership at NRx Pharmaceuticals drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 1.271 | Return On Assets (1.16) | Return On Equity (6.83) |
Technical Drivers
As of the 26th of November, NRx Pharmaceuticals secures the Risk Adjusted Performance of 0.0631, downside deviation of 19.63, and Mean Deviation of 11.18. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NRx Pharmaceuticals, as well as the relationship between them. Please verify NRx Pharmaceuticals standard deviation, as well as the relationship between the value at risk and kurtosis to decide if NRx Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 0.051 per share. As NRx Pharmaceuticals appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.NRx Pharmaceuticals Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NRx Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NRx Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NRx Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NRx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on NRx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NRx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Javitt Daniel C. over six months ago Disposition of 33018 shares by Javitt Daniel C. of NRx Pharmaceuticals at 1.0523 subject to Rule 16b-3 | ||
Kim Bennett over six months ago Insider Trading |
NRx Pharmaceuticals Predictive Daily Indicators
NRx Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NRx Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NRx Pharmaceuticals Forecast Models
NRx Pharmaceuticals' time-series forecasting models are one of many NRx Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NRx Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NRx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NRx Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NRx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NRx Pharmaceuticals. By using and applying NRx Stock analysis, traders can create a robust methodology for identifying NRx entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NRx Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.